You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

SETHOTOPE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sethotope patents expire, and when can generic versions of Sethotope launch?

Sethotope is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in SETHOTOPE is selenomethionine se-75. There is one drug master file entry for this compound. Additional details are available on the selenomethionine se-75 profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SETHOTOPE?
  • What are the global sales for SETHOTOPE?
  • What is Average Wholesale Price for SETHOTOPE?
Summary for SETHOTOPE
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 12
Patent Applications: 98
DailyMed Link:SETHOTOPE at DailyMed
Drug patent expirations by year for SETHOTOPE

US Patents and Regulatory Information for SETHOTOPE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco SETHOTOPE selenomethionine se-75 INJECTABLE;INJECTION 017047-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

SETHOTOPE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of the Stethoscope Market

Introduction

The stethoscope market is undergoing significant transformations driven by technological advancements, increasing prevalence of chronic diseases, and evolving healthcare needs. Here’s a detailed look at the market dynamics and financial trajectory of the stethoscope industry.

Market Size and Growth

The global stethoscope market was estimated at USD 634.93 million in 2023 and is projected to grow at a CAGR of 5.96% from 2024 to 2030[1]. Another report indicates that the market size surpassed USD 658.13 million in 2023 and is predicted to reach around USD 1,178.61 million by 2033, growing at a CAGR of 6%[4].

Key Drivers

Several factors are driving the growth of the stethoscope market:

Increasing Prevalence of Chronic Diseases

The rising prevalence of cardiovascular and respiratory diseases is a significant driver. For instance, ischemic heart disease remains a major contributor to global cardiovascular disease mortality, and the global prevalence of Chronic Obstructive Pulmonary Disease (COPD) is anticipated to increase substantially by 2050[1].

Technological Advancements

The integration of advanced technologies such as digital stethoscopes and artificial intelligence (AI) is boosting market growth. Electronic stethoscopes, which currently hold around 16% of the global market share, are expected to see increased adoption due to their enhanced diagnostic capabilities[2].

Healthcare Infrastructure and Expenditure

Well-developed healthcare infrastructure, particularly in North America, and increasing healthcare expenditure globally are also driving market growth. The e-commerce segment, which offers convenient access to stethoscopes, is expected to show the fastest growth over the forecast period[4].

Regional Analysis

North America

North America dominated the market with a revenue share of 32.64% in 2023 and is expected to continue its dominance. The U.S. stethoscope market is a significant contributor, with revenues expected to grow substantially over the forecast period[1][2].

Asia Pacific

The Asia Pacific region is anticipated to grow at the fastest CAGR due to a substantial patient pool, increased clinical trials, and significant research and development investments. The region's cost-efficient structures and growing awareness about chronic disease treatment are key factors propelling market growth[1].

Market Segmentation

By Product

The market is segmented into manual stethoscopes, mechanical stethoscopes, electronic stethoscopes, esophageal stethoscopes, fetal stethoscopes, and others. Electronic stethoscopes are gaining traction due to their advanced features and improved diagnostic accuracy[2].

By End Use

The market is segmented by end use into physicians' offices, home care settings, hospitals, and others. Physicians' offices are likely to generate the highest revenues during the forecast period[2].

Competitive Landscape

Manufacturers are focusing on creating innovative products to increase sales. Small and medium-sized manufacturers are developing affordable stethoscopes using cheaper components, while prominent players are integrating AI and other advanced technologies to enhance product efficacy and accuracy[2].

Challenges and Restraints

Despite the growth, the market faces several challenges:

Cost of Advanced Stethoscopes

The expensive nature of advanced stethoscopes is expected to hinder market growth, particularly in developing countries where affordability is a significant concern[2].

Lack of Skilled Medical Workers

The lack of skilled medical workers who can operate modern variants of stethoscopes can also negatively influence demand[2].

Impact of Telemedicine and Remote Patient Monitoring

The growing adoption of telemedicine and remote patient monitoring solutions is further propelling market expansion. Manufacturers are developing products that meet the evolving needs of healthcare professionals and patients in these new care models[4].

Key Takeaways

  • The global stethoscope market is projected to grow significantly, driven by technological advancements and the increasing prevalence of chronic diseases.
  • North America and the Asia Pacific region are key markets, with the latter expected to grow at the fastest CAGR.
  • Electronic stethoscopes are gaining traction due to their advanced diagnostic capabilities.
  • The market faces challenges such as the high cost of advanced stethoscopes and the lack of skilled medical workers.
  • The integration of telemedicine and remote patient monitoring is driving market expansion.

FAQs

  1. What is the projected growth rate of the global stethoscope market? The global stethoscope market is projected to grow at a CAGR of 5.96% from 2024 to 2030 and at a CAGR of 6% from 2024 to 2033[1][4].

  2. Which region is expected to dominate the global stethoscope market? North America is expected to continue its dominance in the global stethoscope market, although the Asia Pacific region is anticipated to grow at the fastest CAGR[1][2].

  3. What are the key drivers of the stethoscope market? Key drivers include the increasing prevalence of chronic diseases, technological advancements such as digital stethoscopes and AI, and growing healthcare expenditure[1][2][4].

  4. Which segment of stethoscopes is gaining traction? Electronic stethoscopes are gaining traction due to their enhanced diagnostic capabilities and integration of advanced technologies[2].

  5. What are the challenges facing the stethoscope market? The market faces challenges such as the expensive nature of advanced stethoscopes and the lack of skilled medical workers to operate these devices[2].

Cited Sources

  1. Grand View Research - Stethoscope Market Size, Share, Trends And Report, 2030
  2. PR Newswire - Stethoscope Sales Set to Total US$ 504 Million by 2026 as Advancement in Stethoscope Technology Surges
  3. ASPE - ISSUE BRIEF - International Market Size and Prices
  4. Precedence Research - Stethoscopes Market Size, Share, and Trends 2024 to 2033

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.